risperidone has been researched along with Akinetic-Rigid Variant of Huntington Disease in 15 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risperidone was an effective treatment in this case." | 5.62 | Bilateral chorea following severe traumatic brain injury treated with risperidone. ( Koffer, J; Krasna, D; Montgomery, E; Segal, M, 2021) |
| "Risperidone has been shown in several trials to have a statistically significant benefit when used in a therapeutic context." | 3.01 | Neuropharmacological effect of risperidone: From chemistry to medicine. ( Afzal, O; Al-Abbasi, FA; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Bhat, AA; Dua, K; Gupta, G; Kazmi, I; Singh, SK, 2023) |
| "Risperidone was an effective treatment in this case." | 1.62 | Bilateral chorea following severe traumatic brain injury treated with risperidone. ( Koffer, J; Krasna, D; Montgomery, E; Segal, M, 2021) |
| "UHDRS (Unified Huntington's Disease Rating Scale) motor scores were obtained from medical records as an index of disease progression." | 1.42 | Examining Huntington's disease patient and informant concordance on frontally mediated behaviors. ( Cimino, CR; Hergert, DC; Sanchez-Ramos, J, 2015) |
| "We described a 32-year-old woman with Huntington's disease (HD) who presented with severe chorea, psychosis and cognitive abnormalities." | 1.33 | Clinical experience with risperidone and memantine in the treatment of Huntington's disease. ( Cakir, A; Cankurtaran, ES; Ozalp, E; Soygur, H, 2006) |
| "A positive family history of Huntington's disease and DNA analysis helped to establish the diagnosis." | 1.30 | Psychiatric and neuropsychological abnormalities in Huntington's disease: a case study. ( Brafman, I; Brenner, R; Madhusoodanan, S; Moise, D; Sindagi, J, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bhat, AA | 2 |
| Gupta, G | 2 |
| Afzal, O | 2 |
| Kazmi, I | 2 |
| Al-Abbasi, FA | 2 |
| Alfawaz Altamimi, AS | 2 |
| Almalki, WH | 2 |
| Alzarea, SI | 2 |
| Singh, SK | 2 |
| Dua, K | 2 |
| Krasna, D | 1 |
| Montgomery, E | 1 |
| Koffer, J | 1 |
| Segal, M | 1 |
| Ding, J | 1 |
| Gadit, AM | 1 |
| Hergert, DC | 1 |
| Sanchez-Ramos, J | 1 |
| Cimino, CR | 1 |
| Kao, YH | 1 |
| Chern, Y | 1 |
| Yang, HT | 1 |
| Chen, HM | 1 |
| Lin, CJ | 1 |
| Coppen, EM | 1 |
| Roos, RA | 1 |
| Johnston, TG | 1 |
| Cankurtaran, ES | 1 |
| Ozalp, E | 1 |
| Soygur, H | 1 |
| Cakir, A | 1 |
| Chou, KL | 1 |
| Borek, LL | 1 |
| Friedman, JH | 1 |
| Soliman, S | 1 |
| Haque, S | 1 |
| George, E | 1 |
| Madhusoodanan, S | 2 |
| Brenner, R | 2 |
| Moise, D | 1 |
| Sindagi, J | 1 |
| Brafman, I | 1 |
| Dallocchio, C | 1 |
| Buffa, C | 1 |
| Tinelli, C | 1 |
| Mazzarello, P | 1 |
| Parsa, MA | 1 |
| Szigethy, E | 1 |
| Voci, JM | 1 |
| Meltzer, HY | 1 |
| Erdemoglu, AK | 1 |
| Boratav, C | 1 |
3 reviews available for risperidone and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Neuropharmacological effect of risperidone: From chemistry to medicine.
Topics: Antipsychotic Agents; Humans; Huntington Disease; Psychotic Disorders; Risperidone; Schizophrenia | 2023 |
Neuropharmacological effect of risperidone: From chemistry to medicine.
Topics: Antipsychotic Agents; Humans; Huntington Disease; Psychotic Disorders; Risperidone; Schizophrenia | 2023 |
Neuropharmacological effect of risperidone: From chemistry to medicine.
Topics: Antipsychotic Agents; Humans; Huntington Disease; Psychotic Disorders; Risperidone; Schizophrenia | 2023 |
Neuropharmacological effect of risperidone: From chemistry to medicine.
Topics: Antipsychotic Agents; Humans; Huntington Disease; Psychotic Disorders; Risperidone; Schizophrenia | 2023 |
Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Huntington Disease; Olanzapine; Risperidone; Tetraben | 2017 |
The management of psychosis in movement disorder patients.
Topics: Antipsychotic Agents; Clozapine; Haloperidol; Humans; Huntington Disease; Lewy Body Disease; Parkins | 2007 |
1 trial available for risperidone and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Effectiveness of risperidone in Huntington chorea patients.
Topics: Antipsychotic Agents; Female; Humans; Huntington Disease; Male; Middle Aged; Risperidone; Treatment | 1999 |
11 other studies available for risperidone and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Bilateral chorea following severe traumatic brain injury treated with risperidone.
Topics: Activities of Daily Living; Brain Injuries, Traumatic; Chorea; Humans; Huntington Disease; Male; Ris | 2021 |
Psychosis with Huntington's disease: role of antipsychotic medications.
Topics: Aggression; Antipsychotic Agents; Humans; Huntington Disease; Male; Middle Aged; Psychotic Disorders | 2014 |
Examining Huntington's disease patient and informant concordance on frontally mediated behaviors.
Topics: Adult; Aged; Antipsychotic Agents; Awareness; Cognition Disorders; Disease Progression; Female; Fron | 2015 |
Regulation of P-glycoprotein expression in brain capillaries in Huntington's disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone.
Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological A | 2016 |
Risperidone long-acting injection and Huntington's disease: case series with significant psychiatric and behavioural symptoms.
Topics: Adolescent; Adult; Antipsychotic Agents; Behavioral Symptoms; Cognition; Delayed-Action Preparations | 2011 |
Clinical experience with risperidone and memantine in the treatment of Huntington's disease.
Topics: Adult; Cognition; Dopamine Antagonists; Drug Therapy, Combination; Excitatory Amino Acid Antagonists | 2006 |
Stalking and Huntington's disease: a neurobiological link?
Topics: Aggression; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Female; Fluvoxamine; For | 2007 |
Psychiatric and neuropsychological abnormalities in Huntington's disease: a case study.
Topics: Antipsychotic Agents; Cognition Disorders; Female; Humans; Huntington Disease; Middle Aged; Psychoti | 1998 |
Use of risperidone in psychosis associated with Huntington's disease.
Topics: Antipsychotic Agents; Female; Humans; Huntington Disease; Middle Aged; Psychotic Disorders; Risperid | 1998 |
Risperidone in treatment of choreoathetosis of Huntington's disease.
Topics: Clozapine; Dopamine Antagonists; Female; Humans; Huntington Disease; Middle Aged; Risperidone; Serot | 1997 |
Risperidone in chorea and psychosis of Huntington's disease.
Topics: Adult; Antipsychotic Agents; Female; Humans; Huntington Disease; Psychotic Disorders; Risperidone | 2002 |